Nanobiotix (NBTX) Stock Chart & Stock Price History → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free NBTX Stock Alerts $7.23 -0.03 (-0.41%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Nanobiotix Stock Price Performance5 Day Performance+5.55%1 Month Performance+31.45%3 Month Performance-1.94%6 Month Performance+18.23%Year-To-Date Performance-0.69%1 Year Performance+46.06% Receive NBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. NBTX Stock Chart for Saturday, May, 18, 2024 NBTX Chart by TradingView Nanobiotix Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$7.25$7.23-0.28%$7.41$7.191,741 shs$340.75 million05/16/2024$7.31$7.25-0.82%$7.49$7.252,557 shs$341.71 million05/15/2024$7.29$7.31+0.27%$7.49$7.191,619 shs$344.52 million05/14/2024$6.85$7.29+6.42%$7.39$7.216,168 shs$343.58 million05/13/2024$6.60$6.85+3.79%$7.11$6.709,620 shs$322.84 million05/10/2024$6.67$6.60-1.05%$6.79$6.603,252 shs$311.06 million Get the Latest News and Ratings for NBTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$6.90$6.67-3.33%$6.78$6.671,894 shs$314.36 million05/08/2024$6.41$6.90+7.64%$6.90$6.4024,198 shs$325.20 million05/07/2024$6.32$6.41+1.42%$6.67$6.415,170 shs$302.10 million05/06/2024$6.10$6.32+3.61%$6.51$6.255,233 shs$297.88 million05/03/2024$6.05$6.10+0.83%$6.30$6.102,224 shs$287.49 million05/02/2024$6.00$6.05+0.83%$6.07$6.013,146 shs$285.14 million05/01/2024$5.84$6.00+2.74%$6.19$5.859,168 shs$282.80 million04/30/2024$5.81$5.84+0.52%$5.84$5.711,116 shs$275.24 million04/29/2024$5.74$5.81+1.22%$6.30$5.703,196 shs$273.83 million04/26/2024$5.91$5.74-2.88%$5.87$5.74411 shs$270.53 million04/25/2024$5.90$5.91+0.17%$5.91$5.91439 shs$278.54 million04/24/2024$5.80$5.90+1.72%$5.99$5.901,366 shs$278.07 million04/23/2024$5.73$5.80+1.22%$6.27$5.7126,979 shs$273.35 million04/22/2024$5.41$5.73+5.91%$5.86$5.664,484 shs$270.07 million04/19/2024$5.50$5.41-1.64%$5.55$5.201,565 shs$254.97 million04/18/2024$5.38$5.50+2.23%$5.54$5.3128,362 shs$259.22 million04/17/2024$5.52$5.38-2.54%$5.62$5.1342,841 shs$253.58 million04/16/2024$5.59$5.52-1.25%$5.78$5.503,390 shs$260.16 million04/15/2024$6.09$5.59-8.21%$5.99$5.4524,627 shs$263.46 million04/12/2024$6.18$6.09-1.46%$6.09$5.766,253 shs$287.02 million04/11/2024$6.40$6.18-3.44%$6.18$5.9111,562 shs$291.26 million04/10/2024$6.01$6.40+6.49%$6.40$5.8922,356 shs$301.63 million04/09/2024$6.31$6.01-4.75%$6.21$6.0110,919 shs$283.25 million04/08/2024$6.59$6.31-4.25%$6.39$6.113,848 shs$297.39 million04/05/2024$6.35$6.59+3.78%$6.60$6.2022,366 shs$310.59 million04/04/2024$6.13$6.35+3.59%$6.35$6.1320,929 shs$299.28 million04/03/2024$6.10$6.13+0.49%$6.37$6.0188,069 shs$288.91 million04/02/2024$6.20$6.10-1.61%$6.10$6.101,640 shs$287.49 million04/01/2024$6.50$6.20-4.61%$6.40$6.072,304 shs$292.21 million03/29/2024$6.50$6.50$6.50$6.114,501 shs$306.34 million03/28/2024$6.35$6.50+2.36%$6.50$6.114,481 shs$306.34 million03/27/2024$6.15$6.35+3.25%$6.55$6.152,016 shs$299.28 million03/26/2024$6.12$6.15+0.49%$6.27$6.154,337 shs$289.85 million03/25/2024$6.22$6.12-1.61%$6.68$6.059,032 shs$288.44 millionThe Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.03/22/2024$6.50$6.22-4.31%$6.31$6.221,743 shs$293.15 million03/21/2024$6.20$6.50+4.84%$6.50$6.353,250 shs$306.35 million03/20/2024$6.21$6.20-0.16%$6.39$6.202,977 shs$292.21 million03/19/2024$6.28$6.21-1.11%$6.51$6.212,877 shs$292.68 million03/18/2024$6.95$6.28-9.64%$6.51$6.2124,289 shs$295.98 million03/15/2024$6.26$6.95+11.02%$7.00$6.0547,075 shs$327.55 million03/14/2024$6.35$6.26-1.42%$6.32$6.261,473 shs$295.05 million03/13/2024$6.70$6.35-5.22%$6.35$6.207,915 shs$299.30 million03/12/2024$6.75$6.70-0.74%$6.78$6.215,105 shs$315.77 million03/11/2024$7.04$6.75-4.12%$6.95$6.353,476 shs$318.13 million03/08/2024$6.70$7.04+5.07%$7.19$6.662,154 shs$331.80 million03/07/2024$6.45$6.70+3.88%$6.70$6.543,882 shs$315.77 million03/06/2024$6.60$6.45-2.27%$6.45$6.266,047 shs$303.99 million03/05/2024$6.54$6.60+0.92%$6.60$6.347,168 shs$311.06 million03/04/2024$6.45$6.54+1.40%$6.54$6.453,483 shs$308.25 million03/01/2024$6.25$6.45+3.20%$6.45$6.28940 shs$303.99 million02/29/2024$6.66$6.25-6.16%$6.59$6.059,617 shs$294.56 million02/28/2024$6.54$6.66+1.83%$6.66$6.661,745 shs$313.89 million02/27/2024$6.50$6.54+0.62%$6.63$6.542,236 shs$308.23 million02/26/2024$7.00$6.50-7.14%$6.64$6.303,221 shs$306.35 million02/23/2024$7.00$6.86-2.00%$6.86$6.70536 shs$323.31 million02/22/2024$6.30$7.00+11.11%$7.00$6.708,418 shs$329.91 million02/21/2024$6.35$6.30-0.79%$6.68$6.302,421 shs$296.92 million02/20/2024$7.37$6.35-13.84%$6.89$6.2312,742 shs$299.28 million02/19/2024$7.37$7.37-0.04%$7.39$7.314,200 shs$347.35 million Related Companies: Precigen Stock Chart Atea Pharmaceuticals Stock Chart Verastem Stock Chart AC Immune Stock Chart ADC Therapeutics Stock Chart Kamada Stock Chart Nkarta Stock Chart Nektar Therapeutics Stock Chart Silverback Therapeutics Stock Chart Revance Therapeutics Stock Chart Receive NBTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBTX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA once-in-a-century investment opportunityStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.